The lignan compound matairesinol monoglucoside induces type I interferon production in HBV infection immunity by regulating STING signaling
MMG shows promise as a potential therapeutic agent against HBV by targeting the STING signaling pathway.
Authors
- Zhijun Su (ORCID: https://orcid.org/0000-0003-2849-480X)
- Jiangfu Liu
- Minhua Lin (ORCID: https://orcid.org/0000-0002-6786-5530)
- Minghui Zheng
- Ruyi Guo
- Dawu Zeng
Institutions
- Fujian Medical University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
- Second Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- RSC Medicinal Chemistry
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1039/d5md00468c
- Citations
- 1
- Primary Topic
- interferon and immune responses
- Type
- article
- Field-Weighted Citation Impact
- 0.80